Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
I

Ixekizumab [Taltz]

Availability of ACE Drug Guidance

Yes

Biologics Drug Information Overview

No

Subsidy Information and Financing Scheme

Medical Assistance Fund

Active ingredient: Ixekizumab

General information

Subsidy Information and Financing Scheme

[MAF] Ixekizumab (Taltz) Prefilled Pen 80 mg/mL

  1. Additional clinical criteria applies

  2. Treatment of adult patients with ankylosing spondylitis

  3. Treatment of adult patients with psoriatic arthritis with axial involvement

  4. Treatment of adult patients with psoriatic arthritis with peripheral involvement

  5. Treatment of adult patients with chronic plaque psoriasis

View legend

Drug Guidance for Subsidy

01/06/2023 Ixekizumab and secukinumab for treating active non-radiographic axial spondyloarthritis

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Secukinumab 150 mg/mL solution for injection in prefilled pen for treating adults with active non-radiographic axial spondyloarthritis.

Funding status

[R] Secukinumab 150 mg/mL solution for injection in prefilled pen is recommended for inclusion on the MOH Medication Assistance Fund (MAF) for the abovementioned indication from 1 August 2023.

[R] Secukinumab should be used in line with additional clinical criteria for initial and continuing prescriptions for adult patients with active non-radiographic axial spondyloarthritis.

[NR] MAF assistance does not apply to ixekizumab, or any other formulations or strengths of secukinumab.

View legend

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Availability information

Formulation

Public Healthcare Institution

Taltz Prefilled Pen 80 mg/mL

  1. Changi General Hospital

  2. National Skin Centre

  3. Ng Teng Fong General Hospital

  4. Sengkang General Hospital

  5. Singapore General Hospital

  6. Tan Tock Seng Hospital

Registered Product(s) Information

Clinical and product info

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information.

Subcutaneous

* Clinical information is available for this product.

Back to top